Interleukin-10 production by effector T cells: Th1 cells show self control

Giorgio Trinchieri

The Journal of Experimental Medicine · 2007 · 371 citations · 30 references

DOIFull text

Open access

Concepts

TL;DR

IL‑10, an anti‑inflammatory cytokine originally attributed to Th2 cells, is now known to be produced by various cell types, including CD4⁺ T cells that simultaneously secrete IFN‑γ during infections. Effector Th1 cells produce IL‑10 that restrains inflammatory damage yet can impair pathogen clearance.

Abstract

Interleukin (IL)-10 is a cytokine that modulates both innate and adaptive immunity, primarily by exerting antiinflammatory effects. IL-10 was originally thought to be produced only by T helper (Th)2 cells, but is now known to be made by a variety of cell types. During many infections, CD4+ T cells produce both interferon (IFN)-γ, the signature Th1 cytokine, and IL-10. New data now show that the IL-10 produced by effector Th1 cells helps limit the collateral damage caused by exaggerated inflammation. But this control may also limit the effectiveness of the immune response, resulting in a failure to fully eliminate pathogens.

References

30